The findings suggest Covid vaccines reduced the likelihood of severe illness last fall and winter.
seen from United States
seen from United States
seen from United Kingdom
seen from United States
seen from China

seen from United States
seen from China
seen from Latvia
seen from China
seen from United Kingdom
seen from United States
seen from France
seen from France
seen from France
seen from China
seen from Russia
seen from Japan
seen from United States

seen from United States
seen from United States
The findings suggest Covid vaccines reduced the likelihood of severe illness last fall and winter.
Stabilizer Makes Temperature-Tolerant Vaccines, Antibiotics
Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 F. This provides a new avenue toward eliminating the need to keep some vaccines and antibiotics refrigerated, which could save billions of dollars every year and increase accessibility to third world populations. Vaccines and antibiotics often need to be refrigerated to prevent alteration of their chemical structures; such alteration can result in less potent or ineffective medications. By immobilizing their bioactive molecules using silk protein matrices, researchers were able to protect and stabilize both live vaccines and antibiotics when stored at higher than recommended temperatures for periods far longer than recommended. Read more: http://www.laboratoryequipment.com/news-Stabilizer-Makes-Temperature-Tolerant-Vaccines-Antibiotics-071112.aspx